This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Virtual communications between sales reps and HCPs jumped significantly during 2020, making it more important than ever for pharma companies to maintain up-to-date customer data. The post 4 ways to embed data-driven best practice in pharma HCP communications appeared first on. For more information, visit veeva.com/eu.
COVID-19 might have forced pharma to finally fully embrace digital communications, but that doesn’t mean the industry is good at using these platforms yet. Ian Daley and Jonathan Macdonald from EPG Health tell us how pharma can take cues from companies like Amazon. Responding to dynamic shifts in value communications.
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceuticalcompanies. The evolution of value in healthcare is a trend that has important implications for communications, particularly because ‘value’ is very much in the eye of the beholder.
German pharmaceuticalcompany Merck has appointed Thomas Möller as its new head of group communications. Most recently responsible for corporate communications, Möller has worked at Merck since 2017, when he joined as head of external communications. I am really looking forward to collaborating with him further.”.
The ways in which we communicate and consume information are constantly transforming. In 2020, the challenges of the COVID-19 pandemic greatly accelerated the pace of this evolution, with wide-reaching effects on many aspects of medical communications. Q1: What are some ways in which data dissemination has evolved in 2020?
The pandemic has ushered in a number of major changes to healthcare systems, notably in the ways in which pharmaceuticalcompaniescommunicate, visit and engage with physicians. The webinar will also cover: How HCP engagement changed for pharma in 2020. How engagement with HCPs will evolve in the future.
But learning how to overcome the challenges of 2020 will serve the industry well for years to come. Since the start of the year, pharmaceuticalcompanies have been riding a rollercoaster of challenges. “We As the industry moves from a face-to-face to digital communication model, it needs a change of mindset, he adds. “A
Throughout the year 2020, pharma marketers were forced to explore new strategies in order to keep up with the many evolving trends. Trend #1: Media and Tech: Facilitating Communication. 2020 has taught us that the pharma marketing industry will continue to grow and quickly adapt to the new challenges that are faced in 2021.
The COVID-19 pandemic has been mainstream headline news throughout 2020 and continues to have a profound impact on all our lives. — Professor Karol Sikora (@ProfKarolSikora) April 22, 2020. — Tatiana Prowell, MD (@tmprowell) May 11, 2020. — Aditya Bardia, MD (@ABhealer108) March 14, 2020.
Using content metrics, companies can understand how their current content is received and engaged with, which will, in turn, helps clarify the most effective and efficient ways to connect and communicate with their audience in the future, resulting in increased speed to market and effective content engagement.
The pandemic has triggered a change in how pharmaceuticalcompanies are engaging with healthcare professionals. When IQVIA polled non COVID-19 treating Italian HCPs in March when the crisis was at its worst, it asked HCPs if they still welcomed pharmaceuticalcompany engagement during the crisis. The answer was yes.
In early 2020, health officials were cautious about forecasting a COVID-19 vaccine timeline to the public, as vaccine discovery was a historically laborious process that took years (if not decades). Despite the success tied to the vaccine rollout, analysing data is still a daily challenge for many life sciences and pharmaceuticalcompanies.
In office/in person sales promotion, the staple of pharmaceuticalcompany activities, is simply not possible today with interactions reduced to the sporadic video or to telephone engagement. Understanding how to modify communication style is a first step.
Source: CRA market research (conducted June 2020). More than 100,000 MS patients were included in the data set, defined as patients with two or more MS-related medical claims or one or more MS-related medical claims plus a related pharmacy claim identified between January 2019 and June 2020. Changes in Prescribing by Specialty.
Experts from Executive Insight discuss how a holistic, multi-stakeholder approach can help companies overcome access barriers at all stages. How to improve payer engagement with tailored value communication. Value can mean different things to different payers.
In this episode of our Health Innovators series, Paul Tunnah interviews Graeme Duncan, CEO of specialty pharmaceuticalcompany Advanz Pharma. Graeme discusses his career in the life sciences industry and how Advanz Pharma positions itself as the go-to partner for companies commercialising complex medicines in Europe.
Like other pharmaceuticalcompanies, Vertex still faces challenges with reimbursement and market access. The agreement for Kaftrio followed a long battle with NHS England to make the company’s three other cystic fibrosis medicines available. Early results are positive, it hasn’t changed the mission,” says Lem.
The wave of interest in sustainability follows the value chain from top-tier pharmaceuticalcompanies to their suppliers of every size. About 80% of pharmaceuticalcompanies have announced a commitment to becoming carbon-neutral or made a net-zero pledge for carbon emissions. Where do most organizations start?
The pharmaceutical industry has undergone significant changes in recent years, with digital marketing playing an increasingly important role in the way companiescommunicate with customers and stakeholders. Digital Marketing in the Pharmaceutical Industry: The State of Play. 2020, June 10). References: 1.
From patients, patient bodies, pharmaceuticalcompanies, and academia, to regulatory bodies, public institutions, and small and medium-sized enterprises (SMEs), all key stakeholders must come together to help the patients who most need new medicines to access them as quickly as possible. About the author.
Fresenius Kabi is a global healthcare company specialising in medicines and technologies for infusion, transfusion and clinical nutrition. In August of 2022, Fresenius Kabi announced a three-year plan to add GS1 Data Matrix barcodes, also known as 2D barcodes, to its US pharmaceutical portfolio.
A 2020 survey from DrugsDisclosed.com of 3,346 users of prescription and over the counter (OTC) medicines from the UK and the Nordics revealed that: more than three-quarters of patients do not trust advice from pharmaceuticalcompanies about their medication; 81% feel the pharmaceutical industry influences prescription decisions; and.
“A lot of printed materials have been migrated to digital so that patients can opt-in to receive digital communications or HCPs can receive digital product or disease state information in the form of rep-triggered emails and microsites. Joanna Carlish. The idea is about really tapping into where the customer is in their journey.
Use of these platforms was however already trending up before the crisis, and there’s every sign demand will stay high from now on, according to Sjors van den Camp, commercial director at Online Seminar – a company whose heritage in this sector goes back more than a decade. The crisis that changed everything.
Online communication now seems the natural way to get things done, and the sky’s the limit for what we can achieve for our rare disease patients if we continue to drive this innovation and this openness.”. Connect with Dr Tunnah at [link] or [link].
It can be used for sales, marketing and patient communication materials, in print or digital form. The need to escape pharma’s traditional ways of approaching marketing content is becoming ever-clearer as the impact of 2020’s digital transformation of pharma and healthcare reveals itself. A modular content ecosystem.
Putting together a quarter-billion dollar pharma company from ten mergers in four months is not for the faint-hearted – but that’s what biotech investment guru Francesco de Rubertis has achieved with his latest project Centessa. Focus on Rare: the invisible burden of rare diseases. Digitalising drug discovery.
There was bipartisan support for the program at the hearing and support for measures such as requiring pharmaceuticalcompanies to publish their prices in a password protected site on HRSA's website. Four of the five staffers originally involved in the investigation now work for or lobby for the pharmaceutical industry.
If it’s a tight, complicated market, then doctors are going to be looking for the most compelling argument but lot of pharmaceuticalcompanies fall down by not really presenting their product in the best possible light.”. If your team is fully aware of their value, they feel confident communicating with customers. “I
Sixty-one percent of health care professionals said they communicate with pharma sales reps more now than before COVID-19 and 87% want either all virtual or a mix of virtual and in-person meetings even after the pandemic ends. [2]. So as the focus shifts from cost to value, we are now seeing cloud as a CEO agenda item. References. [1]
A new accelerator programme has launched with the aim of improving engagement between digital health startups and pharmaceuticalcompanies, which sometimes can be held back by the different ways in which the two sectors operate. The FDA also took note, setting up its Digital Health Center for Excellence last September.
Taking more time and effort to deliver comprehensive analysis on country and site selection, as well as more open and honest communication with investigative sites during this process, is essential for providing speed, efficiency and cost-effectiveness. Dr Mieke Borgs has been Head of Clinical Operations Europe at BeiGene since May 2020.
7 Access to digital communications also remains a challenge in some Member States especially for those groups at risk of poverty and social exclusion (7.6 The responsibility of printing paper leaflets is currently a key regulatory obligation for pharmaceuticalcompanies. Article 63 EMA (29 January 2020).
When TS Eliot said humankind cannot stand very much reality, he obviously did not consider the virtual kind which is now heralded as the key for curing and preventing disease and picked as the potential lifeline for R&D in the pharmaceutical industry. “There is a real threat the pharmaceutical R&D industry could move offshore.”
But when the pandemic struck in early 2020, we were found wanting. And we transformed so quickly because the key players communicated and collaborated. Surgical activity in England and Wales alone reduced by a third during 2020, a shortfall estimated to increase to 2.4 This will, inevitably, take longer in some areas.
A 2020 review showed that those with hypothyroidism experience more gut dysbiosis and bacterial overgrowth, marked by notably lower levels of Lactobacillaceae and Bifidobacterium. Another study from 2020 examined the effects of probiotic supplementation on thyroid function in hypothyroid patients. Published January 23, 2020.
In addition, we have seen clear public support and interest in the pharma industry during the pandemic, and it was necessary to communicate this openly to the world. Pharmaceuticalcompanies also have a vast number of devices collecting health and patient data that is stored online.
In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceuticalcompanies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements. Published 2020. EMA/206719/2020 Rev 1.
link] A recent study published by My Green Lab 2 presented data from 74 biotechnology and pharmaceuticalcompanies tracking the change in scope 1, 2, and 3 carbon intensity (measured in tons of CO2 emitted vs. the company’s revenue in USD) since 2015. For pharmaceuticalcompanies, purchased goods (e.g.,
A pharmaceutical quality system (PQS) is a management system used to direct and control a pharmaceuticalcompany with regard to quality. Shelf-Life Extensions for Pharmaceutical Products.” Journal of Validation Technology (26 January 2020). ICH Harmonised Tripartite Guideline Q10: Pharmaceutical Quality System.”
Now most pharmaceuticalcompanies that are global in nature will already encounter this from a European compliance standpoint with the GDPR regulation that is more geared toward the US European union. So, this isn’t really something that would technically be super new to pharmaceuticalcompanies that are global.
ChatGPT: “In a pharmaceutical software engineering context, data integrity refers to the accuracy, consistency, and reliability of data stored in computerized systems. This is a crucial aspect of pharmaceutical software as it directly impacts patient safety. Advances in Neural Information Processing Systems 33 (2020): 1877–901.
In a 2020 survey conducted in a nationally representative sample of 3,133 adults in the USA, 20% of respondents intended to decline a vaccine once available. COVID-19 has prompted an interest in microbiology, immunology, epidemiology, and public health never seen on this scale before. Role of pharma in improving health literacy.
Of these three societal pillars, it is, perhaps surprisingly, business that has stepped up to the plate most assuredly in 2020 – led by some of the world’s strongest brands. There are many other mega pharmaceuticalcompanies in the kill-COVID game: Johnson & Johnson, Sanofi, AstraZeneca, GSK and Roche included.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content